פרמיפקסול טבע ® 0.25 מ"ג

Pays: Israël

Langue: hébreu

Source: Ministry of Health

Achète-le

Ingrédients actifs:

PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE 0.25 MG

Disponible depuis:

SALOMON,LEVIN & ELSTEIN LTD

Code ATC:

N04BC05

forme pharmaceutique:

TABLETS

Mode d'administration:

PER OS

Fabriqué par:

NOVOPHARM LIMITED, CANADA (TEVA GROUP)

Groupe thérapeutique:

PRAMIPEXOLE

indications thérapeutiques:

Treatment of the signs and symptoms of idiopathic Parkinson's Disease, it may be used as monotherapy or in combination with levodopa, as well as symptomatic treatment of moderate to severe idiopathic Restless Legs Syndrome.

Date de l'autorisation:

2011-06-01